Restriction of the CD4+ T-cell receptor repertoire prevents immune pathology in TGF-β1 knockout mice

Laboratory Investigation

Volumn 86, Issue 8, 2006, Pages 815-828

  Robinson, Richard T ^a   French, Margaret A ^a   Kitzmiller, Tamar J ^a   Gorham, James D ^a  

^a DARTMOUTH MEDICAL SCHOOL   (United States)

Author keywords

Hepatitis; Liver; Mouse; T cell; T cell receptor; TGF 1

Indexed keywords

T LYMPHOCYTE RECEPTOR; TRANSFORMING GROWTH FACTOR BETA1;

ALLOGENEIC RESTRICTION; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CD4+ T LYMPHOCYTE; CONTROLLED STUDY; EXPERIMENTAL MODEL; IMMUNOPATHOLOGY; INBRED STRAIN; INFLAMMATION; KNOCKOUT MOUSE; MOUSE; NEWBORN; NONHUMAN; PRIORITY JOURNAL; SURVIVAL; T LYMPHOCYTE ACTIVATION; TRANSGENIC MOUSE;

ANIMALS; ANTIGENS, CD4; BASE SEQUENCE; DNA PRIMERS; FLOW CYTOMETRY; LYMPHOCYTE ACTIVATION; MICE; MICE, INBRED BALB C; MICE, KNOCKOUT; RECEPTORS, ANTIGEN, T-CELL; TRANSFORMING GROWTH FACTOR BETA;

EID: 33746257409     PISSN: 00236837     EISSN: 15300307     Source Type: Journal    
DOI: 10.1038/labinvest.3700439     Document Type: Article

References (44)

1. Boivin GP, O'Toole BA, Orsmby IE, et al. Onset and progression of pathological lesions in transforming growth factor-beta 1-deficient mice. Am J Pathol 1995;146:276-288.
2. Kulkarni AB, Ward JM, Yaswen L, et al. Transforming growth factor-beta 1 null mice. An animal model for inflammatory disorders. Am J Pathol 1995;146:264-275.
3. Gorham JD, Lin JT, Sung JL, et al. Genetic regulation of autoimmune disease: BALB/c background TGF-beta 1-deficient mice develop necroinflammatory IFN-gamma-dependent hepatitis. J Immunol 2001;166:6413-6422.
4. Diebold RJ, Eis MJ, Yin M, et al. Early-onset multifocal inflammation in the transforming growth factor beta 1-null mouse is lymphocyte mediated. Proc Natl Acad Sci USA 1995;92:12215-12219.
5. Rudner LA, Lin JT, Park IK, et al. Necroinflammatory liver disease in BALB/c background, TGF-beta1-deficient mice requires CD4(+) T cells. J Immunol 2003;170:4785-4792.
6. Letterio JJ, Geiser AG, Kulkarni AB, et al. Autoimmunity associated with TGF-beta1-deficiency in mice is dependent on MHC class II antigen expression. J Clin Invest 1996;98:2109-2119.
7. Ahuja SS, Paliogianni F, Yamada H, et al. Effect of transforming growth factor-beta on early and late activation events in human T cells. J Immunol 1993;150(Part 1):3109-3118.
8. Fox FE, Capocasale RJ, Ford HC, et al. Transforming growth factor-beta inhibits human T-cell proliferation through multiple targets. Lymphokine Cytokine Res 1992;11:299-305.
9. McKarns SC, Schwartz RH, Kaminski NE. Smad3 is essential for TGF-beta 1 to suppress IL-2 production and TCR-induced proliferation, but not IL-2-induced proliferation. J Immunol 2004;172:4275-4284.
10. Choudhry MA, Sir O, Sayeed MM. TGF-beta abrogates TCR-mediated signaling by upregulating tyrosine phosphatases in T cells. Shock 2001;15:193-199.
11. Chen CH, Seguin-Devaux C, Burke NA, et al. Transforming growth factor beta blocks Tec kinase phosphorylation, Ca2+ influx, and NFATc translocation causing inhibition of T cell differentiation. J Exp Med 2003;197:1689-1699.
12. Bommireddy R, Saxena V, Ormsby I, et al. TGF-beta 1 regulates lymphocyte homeostasis by preventing activation and subsequent apoptosis of peripheral lymphocytes. J Immunol 2003;170:4612-4622.
13. Bommireddy R, Ormsby I, Yin M, et al. TGF beta 1 inhibits Ca2+-calcineurin-mediated activation in thymocytes. J Immunol 2003;170:3645-3652.
14. Kirberg J, Berns A, von Boehmer H. Peripheral T cell survival requires continual ligation of the T cell receptor to major histocompatibility complex-encoded molecules. J Exp Med 1997;186:1269-1275.
15. Brocker T. Survival of mature CD4T lymphocytes is dependent on major histocompatibility complex class II-expressing dendritic cells. J Exp Med 1997;186:1223-1232.
16. Dorfman JR, Stefanova I, Yasutomo K, et al. CD4+ T cell survival is not directly linked to self-MHC-induced TCR signaling. Nat Immunol 2000;1:329-335.
17. Tan JT, Dudl E, LeRoy E, et al. IL-7 is critical for homeostatic proliferation and survival of naive T cells. Proc Natl Acad Sci USA 2001;98:8732-8737.
18. Geginat J, Campagnaro S, Sallusto F, et al. TCR-independent proliferation and differentiation of human CD4+ T cell subsets induced by cytokines. Adv Exp Med Biol 2002;512:107-112.
19. Le Guiner S, Le Drean E, Labarriere N, et al. LFA-3 costimulates cytokine secretion by cytotoxic T lymphocytes by providing a TCR-independent activation signal. Eur J Immunol 1998;28:1322-1331.
20. Lamphear JG, Stevens KR, Rich RR. Intercellular adhesion molecule-1 and leukocyte function-associated antigen-3 provide costimulation for superantigen-induced T lymphocyte proliferation in the absence of a specific presenting molecule. J Immunol 1998;160:615-623.
21. Bowen DG, Warren A, Davis T, et al. Cytokine-dependent bystander hepatitis due to intrahepatic murine CD8 T- cell activation by bone marrow-derived cells. Gastroenterology 2002;123:1252-1264.
22. Mehal WZ, Azzaroli F, Crispe IN. Antigen presentation by liver cells controls intrahepatic T cell trapping, whereas bone marrow-derived cells preferentially promote intrahepatic T cell apoptosis. J Immunol 2001;167:667-673.
23. Heath WR, Miller JF. Expression of two alpha chains on the surface of T cells in T cell receptor transgenic mice. J Exp Med 1993;178:1807-1811.
24. Saparov A, Kraus LA, Cong Y, et al. Memory/effector T cells in TCR transgenic mice develop via recognition of enteric antigens by a second, endogenous TCR. Int Immunol 1999;11:1253-1264.
25. Shull MM, Ormsby I, Kier AB, et al. Targeted disruption of the mouse transforming growth factor-beta 1 gene results in multifocal inflammatory disease. Nature 1992;359:693-699.
26. Vierling JM. Animal models of autoimmune diseases of the liver. In: Gershwin ME, Vierling JM, Manns MP (eds). Liver Immunology. Hanley & Belfus, Inc.: Philadelphia, 2003, pp 263-290.
27. Heath WR, Carbone FR, Bertolino P, et al. Expression of two T cell receptor alpha chains on the surface of normal murine T cells. Eur J Immunol 1995;25:1617-1623.
28. Padovan E, Casorati G, Dellabona P, et al. Expression of two T cell receptor alpha chains: dual receptor T cells. Science 1993;262:422-424.
29. Hussain MJ, Mustafa A, Gallati H, et al. Cellular expression of tumour necrosis factor-alpha and interferon-gamma in the liver biopsies of children with chronic liver disease. J Hepatol 1994;21:816-821.
30. Lohr HF, Schlaak JF, Gerken G, et al. Phenotypical analysis and cytokine release of liver-infiltrating and peripheral blood T lymphocytes from patients with chronic hepatitis of different etiology. Liver 1994;14:161-166.
31. Strassburg CP, Manns MP. Autoantibodies and autoantigens in autoimmune hepatitis. Semin Liver Dis 2002;22:339-352.
32. Gueguen M, Meunier-Rotival M, Bernard O, et al. Antiliver kidney microsome antibody recognizes a cytochrome P450 from the IID subfamily. J Exp Med 1988;168:801-806.
33. Lapierre P, Hajoui O, Homberg JC, et al. Formiminotransferase cyclodeaminase is an organ-specific autoantigen recognized by sera of patients with autoimmune hepatitis. Gastroenterology 1999;116:643-649.
34. Kita H, Mackay IR, Van De Water J, et al. The lymphoid liver: considerations on pathways to autoimmune injury. Gastroenterology 2001;120:1485-1501.
35. Arenz M, Meyer zum Buschenfelde KH, Lohr HF. Limited T cell receptor Vbeta-chain repertoire of liver-infiltrating T cells in autoimmune hepatitis. J Hepatol 1998;28:70-77.
36. Tanaka A, Iwabuchi S, Takatori M, et al. Clonotypic analysis of T cells in patients with autoimmune and viral hepatitis. Hepatology 1997;25:1070-1076.
37. Hoshino Y, Enomoto N, Izumi N, et al. Limited usage of T-cell receptor beta chains and sequences of the complementarity determining region 3 of lymphocytes infiltrating in the liver of autoimmune hepatitis. Hepatology 1995;22:142-147.
38. Boivin GP, Ormsby I, Jones-Carson J, et al. Germ-free and barrier-raised TGF beta 1-deficient mice have similar inflammatory lesions. Transgenic Res 1997;6:197-202.
39. Sadlack B, Merz H, Schorle H, et al. Ulcerative colitis-like disease in mice with a disrupted interleukin-2 gene. Cell 1993;75:253-261.
40. Bhan AK, Mizoguchi E, Smith RN, et al. Spontaneous chronic colitis in TCR alpha-mutant mice; an experimental model of human ulcerative colitis. Int Rev Immunol 2000;19:123-138.
41. Bayer EM, Herr W, Kanzler S, et al. Transforming growth factor-beta1 in autoimmune hepatitis: correlation of liver tissue expression and serum levels with disease activity. J Hepatol 1998;28:803-811.
42. Sakaguchi K, Kitano M, Nishimura M, et al. Serum level of transforming growth factor-beta1 (TGF-beta1) and the expression of TGF-beta receptor type II in peripheral blood mononuclear cells in patients with autoimmune hepatitis. Hepatogastroenterology 2004;51:1780-1783.
43. Schramm C, Protschka M, Kohler HH, et al. Impairment of TGF-beta signaling in T cells increases susceptibility to experimental autoimmune hepatitis in mice. Am J Physiol Gastrointest Liver Physiol 2003;284:G525-G535.
44. Breitkopf K, Godoy P, Ciuclan L, et al. TGF-beta/Smad signaling in the injured liver. Z Gastroenterol 2006;44:57-66.